• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷Re的药理特性

Pharmacological Properties of Ginsenoside Re.

作者信息

Gao Xiao-Yan, Liu Guan-Cheng, Zhang Jian-Xiu, Wang Ling-He, Xu Chang, Yan Zi-An, Wang Ao, Su Yi-Fei, Lee Jung-Joon, Piao Guang-Chun, Yuan Hai-Dan

机构信息

College of Pharmacy, Yanbian University, Jilin, China.

College of Integration Science, Yanbian University, Jilin, China.

出版信息

Front Pharmacol. 2022 Apr 6;13:754191. doi: 10.3389/fphar.2022.754191. eCollection 2022.

DOI:10.3389/fphar.2022.754191
PMID:35462899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9019721/
Abstract

Ginsenoside Re is a protopanaxatriol-type saponin extracted from the berry, leaf, stem, flower bud, and root of . In recent years, ginsenoside Re (Re) has been attracting attention as a dietary phytochemical. In this review, studies on Re were compiled by searching a combination of keywords, namely "pharmacology," "pharmacokinetics," and "toxicology," in the Google Scholar, NCBI, PubMed, and Web of Science databases. The aim of this review was to provide an exhaustive overview of the pharmacological activities, pharmacokinetics, and toxicity of Re, focusing on clinical evidence that has shown effectiveness in specific diseases, such as diabetes mellitus, nervous system diseases, inflammation, cardiovascular disease, and cancer. Re is also known to eliminate virus, enhance the immune response, improve osteoporosis, improve skin barrier function, enhance intracellular anti-oxidant actions, regulate cholesterol metabolism, alleviate allergic responses, increase sperm motility, reduce erectile dysfunction, promote cyclic growth of hair follicles, and reduce gastrointestinal motility dysfunction. Furthermore, this review provides data on pharmacokinetic parameters and toxicological factors to examine the safety profile of Re. Such data will provide a theoretical basis and reference for Re-related studies and future applications.

摘要

人参皂苷Re是从[植物名称]的浆果、叶、茎、花芽和根中提取的原人参三醇型皂苷。近年来,人参皂苷Re(Re)作为一种膳食植物化学物质受到关注。在本综述中,通过在谷歌学术、NCBI、PubMed和科学网数据库中搜索“药理学”、“药代动力学”和“毒理学”等关键词组合,汇编了关于Re的研究。本综述的目的是全面概述Re的药理活性、药代动力学和毒性,重点关注在糖尿病、神经系统疾病、炎症、心血管疾病和癌症等特定疾病中已显示出有效性的临床证据。Re还已知具有消除病毒、增强免疫反应、改善骨质疏松症、改善皮肤屏障功能、增强细胞内抗氧化作用、调节胆固醇代谢、减轻过敏反应、增加精子活力、减少勃起功能障碍、促进毛囊周期性生长以及减少胃肠动力功能障碍等作用。此外,本综述提供了药代动力学参数和毒理学因素的数据,以研究Re的安全性概况。这些数据将为Re相关研究和未来应用提供理论依据和参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1361/9019721/2270a706bf02/fphar-13-754191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1361/9019721/2270a706bf02/fphar-13-754191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1361/9019721/2270a706bf02/fphar-13-754191-g001.jpg

相似文献

1
Pharmacological Properties of Ginsenoside Re.人参皂苷Re的药理特性
Front Pharmacol. 2022 Apr 6;13:754191. doi: 10.3389/fphar.2022.754191. eCollection 2022.
2
A comprehensive system review of pharmacological effects and relative mechanisms of Ginsenoside Re: Recent advances and future perspectives.人参皂苷 Re 的药理作用及相关机制的综合系统评价:最新进展及未来展望。
Phytomedicine. 2022 Jul 20;102:154119. doi: 10.1016/j.phymed.2022.154119. Epub 2022 May 13.
3
Ginsenoside Rd: A promising natural neuroprotective agent.人参皂苷 Rd:一种有前途的天然神经保护剂。
Phytomedicine. 2022 Jan;95:153883. doi: 10.1016/j.phymed.2021.153883. Epub 2021 Dec 8.
4
Advances in Saponin Diversity of .三萜皂苷多样性的研究进展。
Molecules. 2020 Jul 29;25(15):3452. doi: 10.3390/molecules25153452.
5
Simultaneous determination of notoginsenoside R₁, ginsenoside Rg₁, ginsenoside Re and 20(S) protopanaxatriol in beagle dog plasma by ultra high performance liquid mass spectrometry after oral administration of a Panax notoginseng saponin preparation.口服三七皂苷制剂后,采用超高效液相色谱-质谱联用技术同时测定比格犬血浆中三七皂苷R₁、人参皂苷Rg₁、人参皂苷Re和20(S)-原人参三醇的含量。
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jan 1;974:42-7. doi: 10.1016/j.jchromb.2014.10.025. Epub 2014 Oct 27.
6
UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.基于 UHPLC-MS 的血清和尿液代谢组学揭示了人参皂苷 Re 在 2 型糖尿病大鼠中的抗糖尿病作用机制。
Molecules. 2021 Nov 3;26(21):6657. doi: 10.3390/molecules26216657.
7
Complete Biotransformation of Protopanaxatriol-Type Ginsenosides in Leaf Extract to Aglycon Protopanaxatriol by β-Glycosidases from and .人参三醇型人参皂苷在叶片提取物中通过来自[具体来源1]和[具体来源2]的β-糖苷酶完全生物转化为苷元人参三醇
J Microbiol Biotechnol. 2018 Feb 28;28(2):255-261. doi: 10.4014/jmb.1709.09053.
8
Ginsenoside profiles and related gene expression during foliation in Panax ginseng Meyer.人参叶片分化过程中的人参皂苷成分分析及相关基因表达
J Ginseng Res. 2014 Jan;38(1):66-72. doi: 10.1016/j.jgr.2013.11.001. Epub 2013 Dec 8.
9
Ginsenoside Rh1: A Systematic Review of Its Pharmacological Properties.人参皂苷Rh1:药理特性的系统评价
Planta Med. 2018 Feb;84(3):139-152. doi: 10.1055/s-0043-124087. Epub 2018 Jan 12.
10
Protective Effects and Target Network Analysis of Ginsenoside Rg1 in Cerebral Ischemia and Reperfusion Injury: A Comprehensive Overview of Experimental Studies.人参皂苷Rg1对脑缺血再灌注损伤的保护作用及靶点网络分析:实验研究综述
Cells. 2018 Dec 12;7(12):270. doi: 10.3390/cells7120270.

引用本文的文献

1
Unlocking ginsenosides' therapeutic power with polymer-based delivery systems: current applications and future perspectives.利用基于聚合物的递送系统释放人参皂苷的治疗潜力:当前应用与未来展望。
Front Pharmacol. 2025 Jul 10;16:1629803. doi: 10.3389/fphar.2025.1629803. eCollection 2025.
2
Ginsenoside Re ameliorates thioacetamide-induced acute liver injury through inhibiting autophagy-NLRP3 inflammasome pathway.人参皂苷Re通过抑制自噬-NLRP3炎性小体途径改善硫代乙酰胺诱导的急性肝损伤。
Front Pharmacol. 2025 Jun 20;16:1592203. doi: 10.3389/fphar.2025.1592203. eCollection 2025.
3
Recent Research on the Role of Phytochemicals from Ginseng in Management of Osteosarcoma, Osteoporosis, and Osteoarthritis.

本文引用的文献

1
Simultaneous quantification of twenty-eight components of Shenfu Injection in rat plasma by UHPLC-QQQ MS and its application to a pharmacokinetic study.采用 UHPLC-QQQ MS 同时定量测定参附注射液中 28 种成分在大鼠血浆中的浓度及其药代动力学研究。
J Pharm Biomed Anal. 2021 Sep 5;203:114211. doi: 10.1016/j.jpba.2021.114211. Epub 2021 Jun 16.
2
Comparative pharmacokinetics study of six effective components between two dosage forms of Qixue-Shuangbu Prescription in rats by UPLC-MS/MS.UPLC-MS/MS法研究气血双补方两种剂型中六种有效成分在大鼠体内的比较药代动力学
Biomed Chromatogr. 2021 Oct;35(10):e5179. doi: 10.1002/bmc.5179. Epub 2021 Jun 15.
3
人参中植物化学物质在骨肉瘤、骨质疏松症和骨关节炎治疗中作用的最新研究
Nutrients. 2025 Jun 1;17(11):1910. doi: 10.3390/nu17111910.
4
Application of probiotic bacteria in ginsenoside bioconversion and enhancing its health-promoting benefits: a review.益生菌在人参皂苷生物转化中的应用及其对健康促进益处的增强作用:综述
Food Sci Biotechnol. 2024 Nov 12;34(8):1631-1659. doi: 10.1007/s10068-024-01734-6. eCollection 2025 Apr.
5
Metabolomics-based combination of GH and NVB in the treatment of NSCLC lung cancer recurrence.基于代谢组学的生长激素(GH)与长春瑞滨(NVB)联合治疗非小细胞肺癌(NSCLC)复发
J Cancer. 2025 Jan 1;16(1):265-278. doi: 10.7150/jca.102722. eCollection 2025.
6
Progress of cGAS-STING signaling pathway-based modulation of immune response by traditional Chinese medicine in clinical diseases.基于cGAS-STING信号通路的中药对临床疾病免疫反应调节的研究进展
Front Immunol. 2024 Dec 16;15:1510628. doi: 10.3389/fimmu.2024.1510628. eCollection 2024.
7
Application of microorganisms in Panax ginseng: cultivation of plants, and biotransformation and bioactivity of key component ginsenosides.微生物在人参中的应用:植物的栽培,以及关键成分人参皂苷的生物转化和生物活性。
Arch Microbiol. 2024 Oct 16;206(11):433. doi: 10.1007/s00203-024-04144-8.
8
Ginsenoside Re promotes proliferation of murine bone marrow mesenchymal stem cells in vitro through estrogen-like action.人参皂苷 Re 通过类雌激素作用促进体外培养的小鼠骨髓间充质干细胞增殖。
In Vitro Cell Dev Biol Anim. 2024 Oct;60(9):996-1008. doi: 10.1007/s11626-024-00969-1. Epub 2024 Sep 10.
9
Tongxinluo capsule as a multi-functional traditional Chinese medicine in treating cardiovascular disease: A review of components, pharmacological mechanisms, and clinical applications.通心络胶囊作为治疗心血管疾病的多功能中药:成分、药理机制及临床应用综述
Heliyon. 2024 Jun 21;10(13):e33309. doi: 10.1016/j.heliyon.2024.e33309. eCollection 2024 Jul 15.
10
Free Radical Scavenging Effect and Immunomodulatory Activity of Total Saponins Extract of Ginseng Fibrous Roots.人参须总皂苷的自由基清除作用和免疫调节活性。
Molecules. 2024 Jun 11;29(12):2770. doi: 10.3390/molecules29122770.
Ginsenoside Re protects against chronic restraint stress-induced cognitive deficits through regulation of NLRP3 and Nrf2 pathways in mice.
人参皂苷Re通过调节小鼠的NLRP3和Nrf2通路来预防慢性束缚应激诱导的认知缺陷。
Phytother Res. 2021 May;35(5):2523-2535. doi: 10.1002/ptr.6947. Epub 2021 Mar 29.
4
Ginsenoside Re Treatment Attenuates Myocardial Hypoxia/Reoxygenation Injury by Inhibiting HIF-1α Ubiquitination.人参皂苷Re治疗通过抑制缺氧诱导因子-1α泛素化减轻心肌缺氧/复氧损伤。
Front Pharmacol. 2020 Sep 9;11:532041. doi: 10.3389/fphar.2020.532041. eCollection 2020.
5
Ginsenoside Rh2 attenuates microglial activation against toxoplasmic encephalitis via TLR4/NF-κB signaling pathway.人参皂苷Rh2通过TLR4/NF-κB信号通路减轻小胶质细胞对弓形虫性脑炎的激活作用。
J Ginseng Res. 2020 Sep;44(5):704-716. doi: 10.1016/j.jgr.2019.06.002. Epub 2019 Jun 14.
6
Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury Regulating PI3K/AKT Inhibited HIF-1α/VEGF Signaling Pathway.人参皂苷Re通过调节PI3K/AKT抑制HIF-1α/VEGF信号通路减轻高糖诱导的RF/6A损伤
Front Pharmacol. 2020 May 21;11:695. doi: 10.3389/fphar.2020.00695. eCollection 2020.
7
MiR-30c-5p mediates the effects of panax notoginseng saponins in myocardial ischemia reperfusion injury by inhibiting oxidative stress-induced cell damage.miR-30c-5p 通过抑制氧化应激诱导的细胞损伤来介导三七总皂苷在心肌缺血再灌注损伤中的作用。
Biomed Pharmacother. 2020 May;125:109963. doi: 10.1016/j.biopha.2020.109963. Epub 2020 Feb 7.
8
Ginsenoside metabolite 20(S)-protopanaxatriol from Panax ginseng attenuates inflammation-mediated NLRP3 inflammasome activation.人参皂苷代谢产物 20(S)-原人参三醇可减轻炎症介导的 NLRP3 炎性小体激活。
J Ethnopharmacol. 2020 Apr 6;251:112564. doi: 10.1016/j.jep.2020.112564. Epub 2020 Jan 10.
9
Ginsenoside Re Mitigates 6-Hydroxydopamine-Induced Oxidative Stress through Upregulation of GPX4.人参皂苷 Re 通过上调 GPX4 减轻 6-羟多巴胺诱导的氧化应激。
Molecules. 2020 Jan 2;25(1):188. doi: 10.3390/molecules25010188.
10
Studies of the effects and mechanisms of ginsenoside Re and Rk on myelosuppression induced by cyclophosphamide.人参皂苷Re和Rk对环磷酰胺诱导的骨髓抑制作用及机制的研究。
J Ginseng Res. 2019 Oct;43(4):618-624. doi: 10.1016/j.jgr.2018.07.009. Epub 2018 Aug 30.